至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Overexpression of PSMA7 predicts poor prognosis in patients with gastric cancer.

Oncol Lett. 2019; 
Xia S,,, Tang Q, Wang X, Zhang L, Jia L, Wu D, Xu P, Zhang X, Tang G, Yang T, Feng Z,,,, Lu L.
Products/Services Used Details Operation
Biochemicals … Thermo Fisher Scientific, Inc.). GAPDH was used for monitoring internal standards. Primers were purchased from GenScript. Relative PSMA7 expression was analyzed using the 2-ΔΔCq method (38). PCR primers were designed … Get A Quote

摘要

Gastric cancer (GC) is the fourth most common tumor and the second most common cause of cancer-associated mortality worldwide. Current tumor biomarkers for GC, such as serum carcinoembryonic antigen and carbohydrate antigen 19-9, are not ideal due to their limited role as prognostic indicators for GC. Proteasome subunit α7 (PSMA7) is a multifunctional protein, which has been revealed to be involved in the development and progression of various types of malignancy. However, little is known about the role of PSMA7 in GC. In the present study, PSMA7 was identified to be overexpressed at the mRNA and protein levels in GC tissues, compared with in non-tumor tissues, using reverse transcription-quantitative PCR and ... More

关键词

gastric cancer; prognosis; proteasome subunit α7